183 related articles for article (PubMed ID: 22772338)
21. Assessment of mitotic rate reporting in melanoma.
Burton AL; Egger ME; Gilbert JE; Stromberg AJ; Hagendoorn L; Martin RC; Scoggins CR; McMasters KM; Callender GG
Am J Surg; 2012 Dec; 204(6):969-74; discussion 974-5. PubMed ID: 23036603
[TBL] [Abstract][Full Text] [Related]
22. The magic of numbers: malignant melanoma between science and pseudoscience.
Weyers W
Am J Dermatopathol; 2011 Jun; 33(4):371-8. PubMed ID: 21478727
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
24. Impact of thorough block sampling in the histologic evaluation of melanomas.
Dyson SW; Bass J; Pomeranz J; Jaworsky C; Sigel J; Somach S
Arch Dermatol; 2005 Jun; 141(6):734-6. PubMed ID: 15967919
[TBL] [Abstract][Full Text] [Related]
25. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
26. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
[TBL] [Abstract][Full Text] [Related]
27. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions.
Corona R; Mele A; Amini M; De Rosa G; Coppola G; Piccardi P; Fucci M; Pasquini P; Faraggiana T
J Clin Oncol; 1996 Apr; 14(4):1218-23. PubMed ID: 8648377
[TBL] [Abstract][Full Text] [Related]
28. Inter-observer variation in the histopathology reports of head and neck melanoma; a comparison between the seventh and eighth edition of the AJCC staging system.
Berger DMS; Wassenberg RM; Jóźwiak K; van de Wiel BA; Balm AJM; van den Berg JG; Klop WMC
Eur J Surg Oncol; 2019 Feb; 45(2):235-241. PubMed ID: 30385156
[TBL] [Abstract][Full Text] [Related]
29. Melanoma pathology reporting and staging.
Scolyer RA; Rawson RV; Gershenwald JE; Ferguson PM; Prieto VG
Mod Pathol; 2020 Jan; 33(Suppl 1):15-24. PubMed ID: 31758078
[TBL] [Abstract][Full Text] [Related]
30. Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in western Australia.
Heenan PJ; Matz LR; Blackwell JB; Kelsall GR; Singh A; ten Seldam RE; Holman CD
Histopathology; 1984 Sep; 8(5):717-29. PubMed ID: 6519646
[TBL] [Abstract][Full Text] [Related]
31. Quality of histopathological reporting on melanoma and influence of use of a synoptic template.
Haydu LE; Holt PE; Karim RZ; Madronio CM; Thompson JF; Armstrong BK; Scolyer RA
Histopathology; 2010 May; 56(6):768-74. PubMed ID: 20546342
[TBL] [Abstract][Full Text] [Related]
32. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
33. Population-based method for investigating adherence to international recommendations for pathology reporting of primary cutaneous melanoma: Results of a EUROCARE-5 high resolution study.
Tumino R; Minicozzi P; Frasca G; Allemani C; Crocetti E; Ferretti S; Giacomin A; Natali M; Mangone L; Falcini F; Capocaccia R; Sant M
Cancer Epidemiol; 2015 Jun; 39(3):424-9. PubMed ID: 25735220
[TBL] [Abstract][Full Text] [Related]
34. Histopathologic study of recurrent Clark level II melanomas.
Glass LF; Guffey JM; Schroer KR; Reintgen D
Semin Surg Oncol; 1993; 9(3):202-7. PubMed ID: 8516604
[TBL] [Abstract][Full Text] [Related]
35. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
Barnhill RL; Fine JA; Roush GC; Berwick M
Cancer; 1996 Aug; 78(3):427-32. PubMed ID: 8697387
[TBL] [Abstract][Full Text] [Related]
36. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
37. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness.
Morton DL; Davtyan DG; Wanek LA; Foshag LJ; Cochran AJ
Cancer; 1993 Jun; 71(11):3737-43. PubMed ID: 8490924
[TBL] [Abstract][Full Text] [Related]
38. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
39. Independent prognostic importance of vascular invasion in nodular melanomas.
Straume O; Akslen LA
Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
[TBL] [Abstract][Full Text] [Related]
40. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
